Chemoprevention by pyrimethamine

Immunopharmacology and Immunotoxicology

Volumn 27, Issue 2, 2005, Pages 233-240

  Saadat, Farshid ^a   Khorramizadeh, Mohammad Reza ^a   Mirshafiey, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Cancer; Matrix metalloproteinases; Pyrimethamine

Indexed keywords

ANTIMALARIAL AGENT; GELATINASE A; METHOTREXATE; PYRIMETHAMINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG POTENCY; DRUG TOLERABILITY; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROSARCOMA; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSARCOMA; FOLIC ACID ANTAGONISTS; MATRIX METALLOPROTEINASE 2; METHOTREXATE; PYRIMETHAMINE;

EID: 23244438600     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-200067736     Document Type: Article

References (22)

1. Stetler-Stevenson, W.G.; Hewitt, R.; Corcoran, M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin. Cancer Biol. 1996, 7, 147-154.
2. Jones, L.; Ghaneh, P.; Humphreys, M.; Neoptolemos, J.P. The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer. Ann. N. Y. Acad. Sci. 1999, 880, 288-307.
3. John, A.; Tuszynski, G. The role of matrix metalloproteinase in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 2001, 7, 14-23.
4. Nguyen, M.; Arkell, J.; Jackson, C.J. Human endothelial gelatinases and angiogenesis. Int. J. Biochem. Cell Biol. 2001, 33, 960-970.
5. Ichiyoshi, H.; Kiyozuka, Y.; Kishimoto, Y.; Fukuhara, S.; Tsubura, A. Massive telomere loss and telomerase RNA expression in dexamethasone-induced apoptosis in mouse thymocytes. Exp. Mol. Pathol. 2003, 75, 178-186.
6. Gopalan, B.; Litvak, A.; Sharma, S.; Mhashilkar, A.M.; Chada, S.; Ramesh, R. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Cancer Res. 2005, 65, 3017-3024.
7. Zi, X.; Simoneau, A.R.; Flavokawain, A. A novel chalcone from kava extract induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res. 2005, 65, 3479-3486.
8. Shao, R.; Lee, D.F.; Wen, Y.; Ding, Y.; Xia, W.; Ping, B.; Yagita, H.; Spohn, B.; Hung, M.C. E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation. Mol. Cancer Res. 2005, 3, 219-226.
9. Kundu, T.; Bhattacharya, R.K.; Siddiqi, M.; Roy, M. Correlation of apoptosis with comet formation induced by tea polyphenols in human leukemia cells. J. Environ. Pathol. Toxicol. Oncol. 2005, 24, 115-128.
10. Schurmann, D.; Bergmann, F.; Albrecht, H.; Padberg, J.; Grunewald, T.; Behnsch, M.; Grobusch, M.; Vallee, M.; Wunsche, T.; Ruf, B.; Suttorp, N. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS. J. Infect. 2001, 42, 8-15.
11. Hyde, J.E. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacol. Ther. 1990, 48, 45-59.
12. Hunt, S.Y.; Rezvani, B.B.; Sibley, C.H. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil. Mol. Biochem. Parasitol. 2005, 139, 25-32.
13. Heussen, C.; Dowdle, E.B. Electrophoretic analysis of plasminogen activator in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 1980, 102, 196-202.
14. Shimizu, M.; Hondo, M.; Ito, Y.; Kume, H.; Suzuki, R.; Yamaki, K. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients. Cancer Detect. Prev. 2005, 29, 175-180.
15. Woodworth, C.D.; Michael, E.; Marker, D.; Allen, S.; Smith, L.; Nees, M. Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment. Mol. Cancer Ther. 2005, 4, 650-658.
16. Mader, J.S.; Salsman, J.; Conrad, D.M.; Hoskin, D.W. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol. Cancer Ther. 2005, 4, 612-624.
17. Liao, X.; Tang, S.; Thrasher, J.B.; Griebling, T.L.; Li, B. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol. Cancer Ther. 2005, 4, 505-515.
18. Malerba, I.; Gribaldo, L.; Diodovich, C.; Carloni, M.; Meschini, R.; Bowe, G.; Collotta, A. Induction of apoptosis and inhibition of telomerase activity in human bone marrow and HL-60 p53 null cells treated with anti-cancer drugs. Toxicol. In Vitro 2005, 19, 523-532.
19. Kausch, I.; Jiang, H.; Thode, B.; Doehn, C.; Kruger, S.; Jocham, D. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma. Eur. Urol. 2005, 47, 703-709.
20. Schneider, M. Chemotherapy of epidermoid cancer of the oropharyngeolaryngeal region. Rev. Prat. 1995, 45, 839-842.
21. Liang, Y.; O'Driscoll, L.; McDonnell, S.; Doolan, P.; Oglesby, I.; Duffy, K.; O'Connor, R.; Clynes, M. Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs. Int. J. Cancer 2004, 111, 484-493.
22. Chau, Y.; Tan, F.E.; Langer, R. Synthesis and characterization of dextran-peptide-methotrexate conjugates for tumor targeting via mediation by matrix metalloproteinase II and matrix metalloproteinase IX. Bioconjug. Chem. 2004, 15, 931-941.